2018-09-24 18:32 |
Theranostic radiolabeled nanoparticles for ovarian cancer by folate receptor targeting
Patients with epithelial ovarian cancer (EOC) are frequently diagnosed at stage III/IV with widespread peritoneal carcinomatosis, and have a poor overall survival [1]. Because of current screening techniques do not provide early diagnoses of small volume disease, new methods that enhance the detection and treatment of EOC are needed to improve the prognosis of this type of patients. [...]
MED-016.-
Geneva : CERN, 2018 - 3.
Fulltext: PDF;
|
Record dettagliato - Record simili
|
2018-09-24 18:24 |
Record dettagliato - Record simili
|
2018-09-24 18:15 |
Record dettagliato - Record simili
|
2018-07-23 00:11 |
Record dettagliato - Record simili
|
2018-07-23 00:05 |
Record dettagliato - Record simili
|
2018-07-22 23:58 |
Record dettagliato - Record simili
|
2018-07-22 23:52 |
Record dettagliato - Record simili
|
2018-07-22 23:41 |
Study of lung tumours by using theragnostics with radioactive isotopes of Terbium
In recent years, a number of nuclear-medicine techniques developed for cancer therapy are based on the use of two different radioactive isotopes of the same chemical element, one for diagnosis and the other for therapy; this is the so called theragnostics technique. The diagnostic’s radioisotope will provide the location of the tumour and will decay by gamma emission with a short half-life (hours), whereas the therapeutic radioisotope will attack the tumour by beta/alpha emission having usually a longer half-life (days). [...]
MED-009.-
Geneva : CERN, 2018 - 2.
Fulltext: DOCX;
|
Record dettagliato - Record simili
|
2018-07-22 23:26 |
Development of CXCR4-targeted agents for molecular radiotherapy with 67Cu
CXCR4 is overexpressed in a wide range of malignancies, and agents for the detection and endoradiotherapeutic ablation of this target are entering clinical practice based on the peptide Pentixafor and the isotope pair 68Ga/177Lu. Disadvantages have been demonstrated due to the structural variation on using the different radiometals. [...]
MED-008.-
Geneva : CERN, 2018 - 2.
Fulltext: DOC;
|
Record dettagliato - Record simili
|
2018-07-22 23:17 |
Carbon release study from BN
/ Stegemann, Simon Thomas (KU Leuven (BE))
Hadron therapy, in parcular carbon therapy is a very precise treatment for localized cancers where the tumor is irradiated by a pure and intense carbon beam. Such a treatment reduces the dose delivery to healthy ssue due to the very localized energy deposion at the end of the beam trajectory (Bragg-peak). [...]
MED-007.-
Geneva : CERN, 2018 - 4.
Fulltext: PDF;
|
Record dettagliato - Record simili
|